Day: January 20, 2021

Respiratory Syncytial Virus Therapeutics Market worth USD 4,003.4 Million at 30.9% CAGR; Varying Ethnicity and Climate Difference to Boost Demand in Asia Pacific

Written by Customer Service on January 20, 2021. Posted in Mergers And Acquisitions.

Pune, India, Jan. 20, 2021 (GLOBE NEWSWIRE) — The global Respiratory Syncytial Virus Therapeutics Market size is estimated to showcase potential growth owing to its increasing adoption against the prevention and treatment of the disease, observes Fortune Business Insights™ in an upcoming report, titled, “Respiratory Syncytial Virus Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Prophylaxis and Treatment), By End-user (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Regional Forecast, 2020-2027.” The Respiratory Syncytial Virus Therapeutics Market stood at USD 1,111.3 million in 2019. It is projected to grow from USD 609.2 million in 2020 to USD 4,003.4 million in 2027 at a CAGR of 30.9% in the forecast period.High Production Scale to Hinder Growth Opportunities in Global Pharmaceutical...

Integra LifeSciences Completes the Acquisition of ACell, Inc.

Written by Customer Service on January 20, 2021. Posted in Public Companies.

PRINCETON, N.J., Jan. 20, 2021 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it completed the previously-disclosed acquisition of ACell, Inc.“Acquiring ACell and its proprietary MatriStem UBM™ technologies will enable Integra to provide more comprehensive complex wound management solutions to address our customers’ most pressing clinical challenges,” said Peter Arduini, president and CEO, Integra LifeSciences. “Together with ACell colleagues, we look forward to continuing to advance wound care innovations for our customers and patients.”Sullivan & Cromwell LLP is acting as legal advisor to Integra.About Integra LifeSciencesIntegra LifeSciences is a global leader in regenerative tissue technologies and neurosurgical solutions dedicated...

Sbanken ASA: NO0010920762, Issue Date: 22.01.2021

Written by Customer Service on January 20, 2021. Posted in Public Companies.

Sbanken ASA, NO0010920762, Issue Date: 22.01.2021, FRN Sbanken ASA Bond Issue 2021/2024. Maturity date: 12.12.2024, Amount: NOK 300.000.000,-. The Bond will be listed on Nordic ABM.This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Sbanken ASA: NO0010920762, Emisjonsdato 22.01.2021

Written by Customer Service on January 20, 2021. Posted in Public Companies.

Sbanken ASA, NO0010920762, Emisjonsdato 22.01.2021, emittert nytt obligasjonslån, FRN Sbanken ASA åpent obligasjonslån 2021/2024. Forfallsdato 12.12.2024, NOK 300.000.000,-. Lånet vil bli notert på Nordic ABM.Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12

Blueberries Medical Closes $1M Strategic Financing Led by a Leading Latin American Private Equity Group with Extensive International Cannabis Industry Expertise; Appoints Facundo Garretón as Chairman & Interim CEO

Written by Customer Service on January 20, 2021. Posted in Public Companies.

TORONTO, Jan. 20, 2021 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries“), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce the completion of a non-brokered private placement for aggregate gross proceeds of C$1,000,000 (the “Offering”) from the sale of common shares (“Common Shares”) at a price of C$0.065 per Common Share.The Offering was led by FLA Ventures Ltd. (“FLA Ventures”), a private equity fund based in Buenos Aires, Argentina, which focuses on investments in established and growth-oriented Latin American businesses across a range of sectors, seeking to create and add strategic value, driving their economic growth and enhancing their performances. Blueberries is pleased to welcome FLA Ventures...

Corporate Universe Engages PCAOB Auditor and Investor Relations Firm

Written by Customer Service on January 20, 2021. Posted in Mergers And Acquisitions.

NEW YORK, Jan. 20, 2021 (GLOBE NEWSWIRE) — Corporate Universe, Inc. (OTC: COUV) announced today that it has engaged Accell Audit and Compliance P.A., an SEC PCAOB Audit firm, to audit the Company’s year-end financial statements for calendar years 2019 and 2020 in order to become qualified as a fully audited company. The company has also engaged CORE IR (www.coreir.com) to provide a full suite of public relations and investor relations services, including the creating of a compliant investor relations page for its website and managing shareholder communications. In addition, Carbon-Ion Energy has engaged Sheppard Mullin as legal counsel, ensuring the completion of the merger within the coming weeks.Andrew Sispoidis, Carbon-Ion’s CEO commented, “Each of these practitioners provides an essential service, whether to further the...

Ehave, Inc. Closes 20/20 Global Transaction, Mycotopia Therapy Now Operating as a Publicly Traded Company with Intent to Focus on Psychedelic Sector

Written by Customer Service on January 20, 2021. Posted in Mergers And Acquisitions.

MIAMI, Jan. 20, 2021 (GLOBE NEWSWIRE) — Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leader in digital therapeutics, announced today the Company has closed the transaction to sell 100% of its Mycotopia Therapy subsidiary to 20/20 Global Inc. (OTC Pink: TWGL). As a result of the transaction closing, Ehave controls approximately 75.77% of the outstanding shares of 20/20 Global. 20/20 Global Inc. plans to file with FINRA to change the name of the company to Mycotopia Therapy. Ehave, Inc. and 20/20 Global will file applicable 8k and 6k filings for the transaction with the SEC and SEDAR.Ehave Chairman and CEO Ben Kaplan will serve as Chairman and CEO of both Ehave and 20/20 Global. All payments have been made and stock certificates transferred to complete the transaction. In the future, Ehave management intends to present a plan...

AMMO, Inc. Announces Richard Childress, NASCAR Hall of Fame Member and Former NRA Director, Has Joined its Board of Directors

Written by Customer Service on January 20, 2021. Posted in Public Companies.

– Randy Luth Steps Down from the BoardSCOTTSDALE, Ariz., Jan. 20, 2021 (GLOBE NEWSWIRE) — AMMO, Inc. (Nasdaq: POWW ) (“AMMO” or the “Company”), a premier American ammunition and munition components manufacturer and technology leader, is pleased to announce that Richard Childress, owner of Richard Childress Racing, has joined AMMO’s Board of Directors.Former National Rifle Association (“NRA”) Board First Vice President and NASCAR driver, owner of Richard Childress Racing and Childress Vineyards and 2017 NASCAR Hall of Fame inductee, joined the Company’s Board effective January 19, 2021. “Richard brings more than five decades of incredibly successful business experience to our team, coupled with an unparalleled and well-earned national reputation based upon his stalwart support of our 2nd Amendment rights, service to the industry...

Liquid Media Announces AGM Results and New Director

Written by Customer Service on January 20, 2021. Posted in Public Companies.

VANCOUVER, British Columbia, Jan. 20, 2021 (GLOBE NEWSWIRE) — Liquid Media Group Ltd. (the “Company”, “Liquid Media” or “Liquid”) (Nasdaq: YVR) is pleased to announce that shareholders have voted in favor of all items of business brought before them at the Company’s Annual General Meeting of Shareholders (the “AGM”) held in Vancouver, British Columbia on Thursday, January 14, 2021. All of the nominees listed in the management proxy circular dated December 11, 2020 for the AGM were elected as directors of the Company.Detailed results of the vote for the election of the Class II directors held at the AGM are set out below.Liquid Media is pleased to announce the addition of Ronald W. Thomson to the Company’s Board of Directors, which was approved at the AGM. Earlier this month, Mr. Thomson was appointed CEO...

Imagin Medical Engages Torrey Hills Capital

Written by Customer Service on January 20, 2021. Posted in Public Companies.

VANCOUVER, British Columbia, and BOSTON, Jan. 20, 2021 (GLOBE NEWSWIRE) — via InvestorWire – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (FSE: DPD2) (“Imagin” or the “Company”) is pleased to announce that it has engaged San Diego Torrey Hills Capital, Inc. (“Torrey Hills Capital”), a Rancho Santa Fe, California-based investor relations firm, to provide market awareness and investor relations services to the Company, subject to acceptance by the Canadian Securities Exchange (“CSE”). Cliff Mastricola is the principal of Torrey Hills Capital and will be responsible for all activities related to Imagin.Torrey Hills Capital is a leading investor and financial public relations firm specializing in small and microcap companies and will increase awareness about Imagin through its established...

Day: January 20, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals